FDA Twitter Guidance Lacks Flexibility, And May Be Unconstitutional, Critics Say
This article was originally published in The Gray Sheet
Executive Summary
Stakeholders say the agency’s communication requirements for space-limited online platforms are too restricting and violate the First Amendment. Many of them are calling on the agency to withdraw the guidance and try again. The device industry has a comparatively toned down response so far, but wants more flexibility.
You may also be interested in...
YouTube Videos: Opportunities And Risks For Device Firms
Device-makers that have been reluctant to add product videos to YouTube might need to produce them anyway to counteract inaccurate or even dangerous user videos, one consultant says – but the step isn’t totally without risk. For example, attorney Colleen Heisey questions whether creating online video is the best use of a company’s limited resources: “You have to go viral to have the impact of millions of viewers … so you’re coming up with a digital engagement strategy, and the effort to do that might be better placed elsewhere."
CDRH Sets Date To Examine Patient-Focused Device Labeling Policies
The device center will convene a meeting at FDA headquarters in September to discuss all facets of device patient labeling.
Will #Cures2015 Fix Twitter Promotion?
House 21st Century Cures discussion draft would adjust FDA promotion regulations for Twitter, requiring that information communicated through hyperlink be considered part of the original post.